Expired activity
Please go to the POWER-PAK C.E.® homepage and select a course.

New Treatment Pathways and Patient Management Strategies for Major Depressive Disorder

Co-sponsored by Impact Education, LLC and Postgraduate Institute for Medicine.

Impact Education, LLC       PIM

Release date:

January 15, 2014

Expiration date:

January 31, 2015

Support

Supported by an educational grant from Takeda Pharmaceuticals International, Inc., U.S. Region, and Lundbeck.
Takeda      Lundbeck

FACULTY

Susan W. Butterworth, PhD, MS
Principal, Founder Qconsult

Megan Maroney, PharmD
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Clinical Psychiatric Pharmacist
Monmouth Medical Center

Charles L. Raison, MD
Associate Professor
Department of Psychiatry
College of Medicine
Barry and Janet Lang Associate Professor
John and Doris Norton School of Family and Consumer Sciences

ACCREDITATION STATEMENTS

acpe Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

CREDIT DESIGNATION

Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number – 0809-9999-14-001-H01-P)

Type of Activity: Application
Media: Internet
Estimated time to complete activity: 1 hour

INSTRUCTIONS FOR PARTICIPATION AND CREDIT

Please complete the posttest questions and activity evaluation online at: www.powerpak.com (a username and password are required to access your account). Select this activity using the Sort CE Courses tool at the top of the page to access the posttest. Once completed, click on Submit Posttest at the bottom of the page. Upon passing the exam with a score of 70% or better, you can print out your statement of credit immediately. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the posttest. You will have up to 10 opportunities to pass the posttest.

Transcript information will be sent to the NABP CPE Monitor Service immediately.

TARGET AUDIENCE

This activity has been designed to meet the educational needs of pharmacists practicing in both independent and chain pharmacy settings, involved in the management of patients with major depressive disorder (MDD).

STATEMENT OF NEED/PROGRAM OVERVIEW

MDD is a serious mental illness, characterized by low rates of remission, significant medical comorbidity, and a considerable overall economic toll. To address the educational objectives listed below, this activity will provide instruction on current and emerging treatment recommendations and patient care strategies for pharmacy professionals to use to improve overall clinical, economic, and humanistic outcomes for patients with MDD.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants should be better able to:

  • Recommend current and emerging therapeutic approaches to address the treatment gap created by low rates of remission for patients with MDD
  • Apply newer recommendations from the updated APA Practice Guidelines to ensure appropriate treatment and overall care for patients with MDD
  • Implement evolving patient management techniques to improve outcomes for patients with MDD
  • Provide accurate and appropriate counsel as part of the treatment team.

DISCLOSURE OF CLONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CE activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Name of Faculty or Presenter Reported Financial Relationship
Susan W. Butterworth, PhD, MS No financial interest/relationships relating to the topic of this activity
Megan Maroney, PharmD No financial interest/relationships relating to the topic of this activity
Charles L. Raison, MD Receives consulting fees from Eli Lilly and Company and Pamlab and receives fees for non-CME/CE services from Pamlab. He also serves on the Steering Committee for NACCME and develops CME content for NACCME and CME Incite. His spouse receives a salary from Insys Therapeutics, Inc.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Name of Faculty or Presenter Reported Financial Relationship
Steven Casebeer, MBA No financial interest/relationships relating to the topic of this activity

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer you plan to use meets the following requirements:

  • Operating System: Windows or Macintosh
  • Supported Browsers: Microsoft Internet Explorer, Firefox, Google Chrome, Safari and Opera

For questions relating to the certification of this activity contact Postgraduate Institute for Medicine at information@pimed.com.

Postgraduate Healthcare Education, LLC (PHE) is the source of Power-Pak C.E.® continuing education for health care professionals. Our accredited programs assist in meeting the requirements of licensure. PHE provides continuing education for the broad spectrum of health care professionals. This site features a searchable database of accredited Power-Pak C.E.® courses on important topics for today's health care professionals.

PHE customizes Power-Pak C.E.® online for each visitor by creating a personal participant profile. Registered participants may update their contact information, take an exam, receive instant grading, view their exam history, and print certificates for successfully completed programs at any time. Monthly notifications will be sent to participants notifying you of new courses available on the site.